Episode
Merck Wins FDA Lipfendra Approval, Exoplanet Atmosphere Boosts Habitability Hope, Lifestyle Changes Prevent Dementia, Macrophage Therapy Slows Aging, and more...
- Podcast
- Science News Daily
- Published
- Jul 20, 2026
- Duration seconds
- 688
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/a3345286
Actions
POST https://stenobird.com/v1/public/podcasts/science-news-daily-6698943/episodes/merck-wins-fda-lipfendra-approval-exoplanet-atmosphere-boosts-habitability-hope-lifestyle-changes-prevent-dementia-macrophage-therapy-slows-aging-and-more/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/science-news-daily-6698943/merck-wins-fda-lipfendra-approval-exoplanet-atmosphere-boosts-habitability-hope-lifestyle-changes-prevent-dementia-macrophage-therapy-slows-aging-and-more.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
(0:10): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients (2:03): Discovery of Atmosphere on Rocky Exoplanet LHS 1140 b Boosts Hope for Habitability (4:19): WHO: Up to 45% of Dementia Cases Preventable with Lifestyle Changes (6:39): Targeted Macrophage Therapy Slows Aging, Improves Health in Mice: A Step Toward Human Applications (8:51): Aral Sea Drying Releases 748 Million Tons of CO2, Transforming Carbon Sink into Major Emissions Source To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: WSOC TV